Gene · 1616
Papers3,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Telomere Shortening and p16-Associated Senescence in Myofibromas. | Lab Invest | 2026 | 42217546 | PubTator, text mining | PubMed |
| Clinicopathological and molecular determinants of pancreatic neuroendocrine tumors: toward precision risk stratification. | J Transl Med | 2026 | 42216004 | PubTator, text mining | PubMed |
| Epigenetic regulation of transgenes. | J Biotechnol | 2026 | 42214794 | PubTator, text mining | PubMed |
| Expression of ATRX, DAXX, PDX1, ARX, and somatostatin receptors in pancreatic neuroendocrine tumors: a clinicopathological study. | Front Endocrinol (Lausanne) | 2026 | 42199802 | PubTator, text mining | PubMed |
| APC-rearranged solid pseudopapillary neoplasm-pancreatic neuroendocrine tumor collision tumor: a molecularly resolved case report. | Front Oncol | 2026 | 42180061 | PubTator, text mining | PubMed |
| Somatic mutational profiling identifies aggressive and indolent disease phenotypes in well-differentiated pancreatic neuroendocrine tumors. | Front Oncol | 2026 | 42180048 | PubTator, text mining | PubMed |
| Case Report: triple therapy with pembrolizumab, ipilimumab, and lenvatinib in mitotane- and radiation-refractory, cortisol-secreting stage IV adrenocortical carcinoma: a genomically guided approach. | Front Immunol | 2026 | 42158873 | PubTator, text mining | PubMed |
| Case Report: Identification of rare H3-3A p.G35W variant in a case of adolescent tectal plate low-grade glioma. | Front Oncol | 2026 | 42147219 | PubTator, text mining | PubMed |
| A Rare Case of Pancreatic Neuroendocrine Tumor with Intraductal Extension in the Dorsal Duct of a Pancreas Divisum. | Reports (MDPI) | 2026 | 42029452 | PubTator, text mining | PubMed |
| Mobile elements in pituitary neuroendocrine tumors: integrative evidence and future directions. | Endocr Relat Cancer | 2026 | 42012999 | PubTator, text mining | PubMed |
| ATRX loss in sarcomas is associated with dysregulated gene and transposable element expression, loss of DNA methylation, and worse survival. | ESMO Rare Cancers | 2026 | 41994103 | PubTator, text mining | PubMed |
| Non-canonical histone H3.3 and its chaperones HIRA and DAXX participate in the regulation of KSHV latency. | bioRxiv | 2026 | 41993451 | PubTator, text mining | PubMed |
| DAXX directs dual modes of H3.4-to-H3.3 histone replacement in the male germline. | Genes Dev | 2026 | 41980770 | PubTator, text mining | PubMed |
| The ATRXt Protein Represses rDNA Transcription While Mirroring ATRX Interactions and Heterochromatin Localization. | Int J Mol Sci | 2026 | 41977290 | PubTator, text mining | PubMed |
| Presence of IDH2 and TP53 mutations significantly reduces survival of patients with chondrosarcoma. | Cancer | 2026 | 41906217 | PubTator, text mining | PubMed |
| Distinct DAXX effector modules separate H3.3 nucleosome assembly from ERV silencing. | bioRxiv | 2026 | 41877993 | PubTator, text mining | PubMed |
| Discovery of novel murine PML isoforms. | Nucleus | 2026 | 41871027 | PubTator, text mining | PubMed |
| Systematic identification of variant-specific RNA structure-small molecule interactions exemplified by RNA G-quadruplexes. | Nat Commun | 2026 | 41857008 | PubTator, text mining | PubMed |
| SERBP1 is required for efficient HR repair and cisplatin chemoresistance in lung adenocarcinoma. | Cell Death Discov | 2026 | 41856985 | PubTator, text mining | PubMed |
| Transient SUMOylation inhibition in human pre-adipocytes stably imprints a transcriptional beiging fate. | Nucleic Acids Res | 2026 | 41854078 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1616/papers?page=2